Here, after demonstrating the beneficial effect of central cholinergic activation by a M1mAChR agonist in DNBS-colitis, we demonstrate that this effect is accompanied by a downregulation of IFN-γ and IL-17, IL-1 β, IL-6 and TNF-α levels in colonic tissues. Here, IL17A is linked to colitis.